These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease? Akdoğan M, Parlak E, Kayhan B, Balk M, Saydam G, Sahin B. Turk J Gastroenterol; 2003 Sep; 14(3):181-4. PubMed ID: 14655062 [Abstract] [Full Text] [Related]
26. Multiple epithelial cysts of the spleen and on the splenic capsule, and high serum levels of CA19-9, CA125 and soluble IL-2 receptor. Hashimoto T, Sugino T, Fukuda T, Hoshi N, Ogura G, Watanabe K, Satoh Y, Hasegawa T, Ohishi A, Haga J, Miyata M, Suzuki T. Pathol Int; 2004 May; 54(5):349-54. PubMed ID: 15086840 [Abstract] [Full Text] [Related]
27. [A case of mediastinal mature teratoma presenting increased serum CA19-9 level]. Minami H, Itoyanagi N, Kubota F, Nakamura Y. Nihon Kyobu Geka Gakkai Zasshi; 1994 Nov; 42(11):2139-43. PubMed ID: 7836831 [Abstract] [Full Text] [Related]
33. [Renal cell carcinoma presenting high serum level of CA19-9 due to hydronephrosis: a case report]. Funahashi Y, Kamihira O, Hagikura S, Kasugai S, Kimura K, Fukatsu A, Matsuura O. Nihon Hinyokika Gakkai Zasshi; 2008 Jan; 99(1):39-42. PubMed ID: 18260347 [Abstract] [Full Text] [Related]
35. [Mediastinal mature teratoma perforating into the lung with elevated serum carbohydrate antigen 19-9 (CA19-9) levels; report of a case]. Kimura C, Kamiyoshihara M, Sakata K, Itoh H, Morishita Y. Kyobu Geka; 2003 Mar; 56(3):247-50. PubMed ID: 12649920 [Abstract] [Full Text] [Related]
36. [A case of CEA and CA19-9 producing recurrent transitional cell carcinoma in an Indiana pouch after total cystectomy]. Miyoshi Y, Asakura T, Matsuzaki J, Fukuda M, Satomi Y, Akabane H. Hinyokika Kiyo; 1996 Dec; 42(12):961-4. PubMed ID: 9013232 [Abstract] [Full Text] [Related]
37. [Increased CA19-9 level in serum and bronchoalveolar lavage fluid from a patient with pulmonary tuberculosis]. Ishiura Y, Fujimura M, Minami S, Ueda A, Iwata M, Watanabe K, Shinagawa T, Yasui M, Matsuda T, Kitagawa M. Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Apr; 34(4):477-81. PubMed ID: 8691672 [Abstract] [Full Text] [Related]
39. CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions. Marrelli D, Caruso S, Pedrazzani C, Neri A, Fernandes E, Marini M, Pinto E, Roviello F. Am J Surg; 2009 Sep; 198(3):333-9. PubMed ID: 19375064 [Abstract] [Full Text] [Related]
40. Movement of a novel serum tumour marker, RCAS1, in patients with biliary diseases. Enjoji M, Yamaguchi K, Nakamuta M, Nakashima M, Kotoh K, Tanaka M, Nawata H, Watanabe T. Dig Liver Dis; 2004 Sep; 36(9):622-7. PubMed ID: 15460847 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]